Characterization of the antibody response to SARS-CoV-2 in a mildly affected pediatric population.
Sonja KopanjaPia GattingerKlara SchmidthalerJustyna SieberKatarzyna NiepodzianaThomas SchledererLukas WeseslindtnerKarin StiasnyFlorian GötzingerWinfried F PicklThomas FrischerRudolph ValentaZsolt SzépfalusiPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2022)
SARS-CoV-2 asymptomatic and mildly affected pediatric patients develop a SARS-CoV-2-specific antibody response, which is comparable regarding antigen, epitope recognition, and the ability to inhibit the RBD-ACE2 interaction to that observed in adult patients after mild COVID-19.